UnitedHealth Group Incorporated $UNH Holdings Lifted by Grant Private Wealth Management Inc

Grant Private Wealth Management Inc boosted its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 44.3% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 4,117 shares of the healthcare conglomerate’s stock after acquiring an additional 1,263 shares during the quarter. UnitedHealth Group comprises about 0.7% of Grant Private Wealth Management Inc’s investment portfolio, making the stock its 26th biggest holding. Grant Private Wealth Management Inc’s holdings in UnitedHealth Group were worth $1,711,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also made changes to their positions in UNH. Norges Bank bought a new stake in UnitedHealth Group during the fourth quarter worth approximately $4,376,167,000. T. Rowe Price Investment Management Inc. increased its holdings in shares of UnitedHealth Group by 141.9% in the fourth quarter. T. Rowe Price Investment Management Inc. now owns 4,109,029 shares of the healthcare conglomerate’s stock valued at $1,356,432,000 after buying an additional 2,410,128 shares in the last quarter. Cardano Risk Management B.V. boosted its stake in shares of UnitedHealth Group by 864.4% during the 4th quarter. Cardano Risk Management B.V. now owns 2,523,700 shares of the healthcare conglomerate’s stock worth $833,099,000 after acquiring an additional 2,262,006 shares in the last quarter. Bank of America Corp DE raised its position in shares of UnitedHealth Group by 21.8% during the first quarter. Bank of America Corp DE now owns 11,713,684 shares of the healthcare conglomerate’s stock worth $3,169,606,000 after purchasing an additional 2,097,859 shares during the period. Finally, Hsbc Holdings PLC lifted its holdings in shares of UnitedHealth Group by 87.5% during the fourth quarter. Hsbc Holdings PLC now owns 3,916,041 shares of the healthcare conglomerate’s stock valued at $1,294,367,000 after purchasing an additional 1,826,948 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on UNH shares. Oppenheimer boosted their price objective on UnitedHealth Group from $420.00 to $500.00 and gave the stock an “outperform” rating in a report on Friday, July 17th. Sanford C. Bernstein reissued an “outperform” rating on shares of UnitedHealth Group in a research report on Tuesday, July 21st. Truist Financial upped their price target on shares of UnitedHealth Group from $440.00 to $480.00 and gave the company a “buy” rating in a research report on Tuesday, July 14th. Robert W. Baird upgraded shares of UnitedHealth Group from an “underperform” rating to a “neutral” rating and lifted their price objective for the stock from $287.00 to $453.00 in a research report on Thursday, July 16th. Finally, DA Davidson set a $512.00 target price on UnitedHealth Group in a report on Tuesday, July 21st. Two research analysts have rated the stock with a Strong Buy rating, twenty have given a Buy rating and five have assigned a Hold rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $455.92.

UnitedHealth Group Price Performance

NYSE UNH opened at $408.15 on Wednesday. The company has a 50 day simple moving average of $412.54 and a 200-day simple moving average of $349.40. UnitedHealth Group Incorporated has a 52-week low of $239.50 and a 52-week high of $461.62. The firm has a market capitalization of $370.66 billion, a price-to-earnings ratio of 26.26, a price-to-earnings-growth ratio of 1.44 and a beta of 0.62. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.78 and a quick ratio of 0.80.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Thursday, July 16th. The healthcare conglomerate reported $6.38 earnings per share for the quarter, beating the consensus estimate of $4.94 by $1.44. The firm had revenue of $112.03 billion for the quarter, compared to analyst estimates of $110.81 billion. UnitedHealth Group had a net margin of 3.14% and a return on equity of 16.53%. The company’s revenue for the quarter was up .4% compared to the same quarter last year. During the same quarter in the prior year, the business earned $4.08 EPS. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. Equities research analysts predict that UnitedHealth Group Incorporated will post 19.69 earnings per share for the current fiscal year.

UnitedHealth Group Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, June 23rd. Investors of record on Monday, June 15th were given a dividend of $2.32 per share. The ex-dividend date of this dividend was Monday, June 15th. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $2.21. This represents a $9.28 dividend on an annualized basis and a yield of 2.3%. UnitedHealth Group’s payout ratio is 59.72%.

About UnitedHealth Group

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.